跳至主要内容
临床试验/NCT00903279
NCT00903279撤回2 期

Treatment of Patients Colonized With Methicillin-Resistant Staphylococcus Aureus Prior to Bone and Joint Surgery (TOPS-MRSA)

Bay Pines VA Healthcare System1 个研究点 分布在 1 个国家开始时间: 2009年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
撤回
试验地点
1
主要终点
Evaluate efficacy of Retapamulin 1% ointment in eliminating patients MRSA colonization

研究概览

简要总结

The investigators anticipate that utilization of retapamulin preoperatively will eliminate MRSA colonization among patients who are colonized in their nares.

详细描述

Enhanced characterization of MRSA strains carried by patients and their eradication prior to surgery will significantly reduce healthcare costs to the VA by reducing the number of MRSA positive patients who need to be isolated and or closely monitored, and allow healthcare providers to better predict the patient's requirements. In addition, the application of molecular methods will facilitate faster tracking of MRSA postoperative infections.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients who are admitted for an orthopedic surgical procedure
  • All patients will be screened and admitted to the study prior to surgery regardless of eventual culture results for MRSA

排除标准

  • Pregnancy
  • Serious systemic illness due to renal, cardiac or hepatic disease
  • Inability to complete follow-up assessments
  • Allergy or intolerance to retapamulin
  • BMI > 30
  • Uncontrolled diabetes, severe anemia, thrombocytopenia or an underlying hematopoietic disorder or malignancy
  • Patients with serious life-threatening illnesses and those with terminal illness not expected to survive for two years or more will not be enrolled
  • Antibiotics administered during the course of the study will be recorded (name, dose and dates)

研究组 & 干预措施

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

Altabax

Experimental

干预措施: Altabax (retapamulin) (Drug)

结局指标

主要结局

Evaluate efficacy of Retapamulin 1% ointment in eliminating patients MRSA colonization

时间窗: 30 days

次要结局

  • Identify a predominant clone among the MRSA isolates in this study(2 years)

研究者

申办方类型
Fed

研究点 (1)

Loading locations...

相似试验

Treatment of Patients Colonized With... | 临床试验